|
1
|
Jiang M, Wang T, Yan X, Liu Z, Yan Y, Yang
K, Qi J, Zhou H, Qian N, Zhou Q, et al: A novel rhein derivative
modulates bone formation and resorption and ameliorates
estrogen-dependent bone loss. J Bone Miner Res. 34:361–374.
2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Yadav VK, Balaji S, Suresh PS, Liu XS, Lu
X, Li Z, Guo XE, Mann JJ, Balapure AK, Gershon MD, et al:
Pharmacological inhibition of gut-derived serotonin synthesis is a
potential bone anabolic treatment for osteoporosis. Nat Med.
16:308–312. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
3
|
Black DM and Rosen CJ: Clinical practice.
Postmenopausal osteoporosis. N Engl J Med. 374:254–262.
2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Canalis E: Management of endocrine
disease: Novel anabolic treatments for osteoporosis. Eur J
Endocrinol. 178:R33–R44. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Riggs BL and Hartmann LC: Selective
estrogen-receptor modulators-mechanisms of action and application
to clinical practice. N Engl J Med. 348:618–629. 2003.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Leder BZ: Parathyroid hormone and
parathyroid hormone-related protein analogs in osteoporosis
therapy. Curr Osteoporos Rep. 15:110–119. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Luo J, Zhou W, Zhou X, Li D, Weng J, Yi Z,
Cho SG, Li C, Yi T, Wu X, et al: Regulation of bone formation and
remodeling by G-protein-coupled receptor 48. Development.
136:2747–2756. 2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Xu JG, Huang C, Yang Z, Jin M, Fu P, Zhang
N, Luo J, Li D, Liu M, Zhou Y and Zhu Y: Crystal structure of
LGR4-Rspo1 complex: Insights into the divergent mechanisms of
ligand recognition by leucine-rich repeat G-protein-coupled
receptors (LGRs). J Biol Chem. 290:2455–2465. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
de Lau W, Barker N, Low TY, Koo BK, Li VS,
Teunissen H, Kujala P, Haegebarth A, Peters PJ, van de Wetering M,
et al: Lgr5 homologues associate with Wnt receptors and mediate
R-spondin signalling. Nature. 476:293–297. 2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Jaks V, Barker N, Kasper M, van Es JH,
Snippert HJ, Clevers H and Toftgård R: Lgr5 marks cycling, yet
long-lived, hair follicle stem cells. Nat Genet. 40:1291–1299.
2008.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
Barker N, Huch M, Kujala P, van de
Wetering M, Snippert HJ, van Es JH, Sato T, Stange DE, Begthel H,
van den Born M, et al: Lgr5(+ve) stem cells drive self-renewal in
the stomach and build long-lived gastric units in vitro. Cell Stem
Cell. 6:25–36. 2010.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Barker N, van Es JH, Kuipers J, Kujala P,
van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H,
Peters PJ and Clevers H: Identification of stem cells in small
intestine and colon by marker gene Lgr5. Nature. 449:1003–1007.
2007.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Morita H, Mazerbourg S, Bouley DM, Luo CW,
Kawamura K, Kuwabara Y, Baribault H, Tian H and Hsueh AJ: Neonatal
lethality of LGR5 null mice is associated with ankyloglossia and
gastrointestinal distension. Mol Cell Biol. 24:9736–9743.
2004.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kemper K, Prasetyanti PR, De Lau W,
Rodermond H, Clevers H and Medema JP: Monoclonal antibodies against
Lgr5 identify human colorectal cancer stem cells. Stem Cells.
30:2378–2386. 2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tanese K, Fukuma M, Yamada T, Mori T,
Yoshikawa T, Watanabe W, Ishiko A, Amagai M, Nishikawa T and
Sakamoto M: G-protein-coupled receptor GPR49 is up-regulated in
basal cell carcinoma and promotes cell proliferation and tumor
formation. Am J Pathol. 173:835–843. 2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Nakata S, Campos B, Bageritz J, Bermejo
JL, Becker N, Engel F, Acker T, Momma S, Herold-Mende C, Lichter P,
et al: LGR5 is a marker of poor prognosis in glioblastoma and is
required for survival of brain cancer stem-like cells. Brain
Pathol. 23:60–72. 2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Vieira GC, Chockalingam S, Melegh Z,
Greenhough A, Malik S, Szemes M, Park JH, Kaidi A, Zhou L,
Catchpoole D, et al: LGR5 regulates pro-survival MEK/ERK and
proliferative Wnt/beta-catenin signalling in neuroblastoma.
Oncotarget. 6:40053–40067. 2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhu C, Zheng XF, Yang YH, Li B, Wang YR,
Jiang SD and Jiang LS: LGR4 acts as a key receptor for R-spondin 2
to promote osteogenesis through Wnt signaling pathway. Cell Signal.
28:989–1000. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Liu SL, Zhou YM, Tang DB, Zhou N, Zheng
WW, Tang ZH, Duan CW, Zheng L and Chen J: LGR6 promotes
osteogenesis by activating the Wnt/β-catenin signaling pathway.
Biochem Biophys Res Commun. 519:1–7. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Scannell CA, Pedersen EA, Mosher JT, Krook
MA, Nicholls LA, Wilky BA, Loeb DM and Lawlor ER: LGR5 is expressed
by ewing sarcoma and potentiates Wnt/β-catenin signaling. Front
Oncol. 3(81)2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Lin W, Xu L, Pan Q, Lin S, Feng L, Wang B,
Chen S, Li Y, Wang H, Li Y, et al: Lgr5-overexpressing mesenchymal
stem cells augment fracture healing through regulation of Wnt/ERK
signaling pathways and mitochondrial dynamics. FASEB J.
33:8565–8577. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Krishnan V, Bryant HU and Macdougald OA:
Regulation of bone mass by Wnt signaling. J Clin Invest.
116:1202–1209. 2006.PubMed/NCBI View
Article : Google Scholar
|
|
24
|
Carmon KS, Gong X, Lin Q, Thomas A and Liu
Q: R-spondins function as ligands of the orphan receptors LGR4 and
LGR5 to regulate Wnt/beta-catenin signaling. Proc Natl Acad Sci
USA. 108:11452–11457. 2011.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Glinka A, Dolde C, Kirsch N, Huang YL,
Kazanskaya O, Ingelfinger D, Boutros M, Cruciat CM and Niehrs C:
LGR4 and LGR5 are R-spondin receptors mediating Wnt/β-catenin and
Wnt/PCP signalling. EMBO Rep. 12:1055–1061. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Gong X, Carmon KS, Lin Q, Thomas A, Yi J
and Liu Q: LGR6 is a high affinity receptor of R-spondins and
potentially functions as a tumor suppressor. PLoS One.
7(e37137)2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Yoon JK and Lee JS: Cellular signaling and
biological functions of R-spondins. Cell Signal. 24:369–377.
2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yamada W, Nagao K, Horikoshi K, Fujikura
A, Ikeda E, Inagaki Y, Kakitani M, Tomizuka K, Miyazaki H, Suda T
and Takubo K: Craniofacial malformation in R-spondin2 knockout
mice. Biochem Biophys Res Commun. 381:453–458. 2009.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhang H, Han X, Wei B, Fang J, Hou X, Lan
T and Wei H: RSPO2 enhances cell invasion and migration via the
WNT/β-catenin pathway in human gastric cancer. J Cell Biochem.
120:5813–5824. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Friedman MS, Oyserman SM and Hankenson KD:
Wnt11 promotes osteoblast maturation and mineralization through
R-spondin 2. J Biol Chem. 284:14117–14125. 2009.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Leucht P, Minear S, Ten Berge D, Nusse R
and Helms JA: Translating insights from development into
regenerative medicine: The function of Wnts in bone biology. Semin
Cell Dev Biol. 19:434–443. 2008.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Baron R and Kneissel M: WNT signaling in
bone homeostasis and disease: From human mutations to treatments.
Nat Med. 19:179–192. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
33
|
Barker N and Clevers H: Leucine-rich
repeat-containing G-protein-coupled receptors as markers of adult
stem cells. Gastroenterology. 138:1681–1696. 2010.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Liu D, He XC, Qian P, Barker N, Trainor
PA, Clevers H, Liu H and Li L: Leucine-rich repeat-containing
G-protein-coupled receptor 5 marks short-term hematopoietic stem
and progenitor cells during mouse embryonic development. J Biol
Chem. 289:23809–23816. 2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Plaks V, Brenot A, Lawson DA, Linnemann
JR, Van Kappel EC, Wong KC, de Sauvage F, Klein OD and Werb Z:
Lgr5-expressing cells are sufficient and necessary for postnatal
mammary gland organogenesis. Cell Rep. 3:70–78. 2013.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Xu L, Lin W, Wen L and Li G: Lgr5 in
cancer biology: Functional identification of Lgr5 in cancer
progression and potential opportunities for novel therapy. Stem
Cell Res Ther. 10(219)2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Luo J, Yang Z, Ma Y, Yue Z, Lin H, Qu G,
Huang J, Dai W, Li C, Zheng C, et al: LGR4 is a receptor for RANKL
and negatively regulates osteoclast differentiation and bone
resorption. Nat Med. 22:539–546. 2016.PubMed/NCBI View Article : Google Scholar
|
